Back

ATRIP deficiency impairs the replication stress response and manifests as microcephalic primordial dwarfism and immunodeficiency.

Duthoo, E.; Beyls, E.; Backers, L.; Gudjonsson, T.; Huang, P.; Jonckheere, L.; Riemann, S.; Parton, B.; Du, L.; Debacker, V.; De Bruyne, M.; Hoste, L.; Baeyens, A.; Vral, A.; Van Braeckel, E.; Staal, J.; Mortier, G.; Kerre, T.; Pan-Hammarström, Q.; Sorensen, C. S.; Haerynck, F.; Claes, K. B.; Tavernier, S. J.

2024-07-23 allergy and immunology
10.1101/2024.07.22.24310550
Show abstract

ATR (Ataxia Telangiectasia and Rad3-related) kinase and its interacting protein ATRIP orchestrate the replication stress response. Two patients of independent ancestry with microcephaly, primordial dwarfism, and recurring infections were found to be homozygous for splice donor site variants of ATRIP exon 5, resulting in ATRIP deficiency. The c.829+5G>T patient exhibited autoimmune hemolytic anemia, lymphopenia, poor vaccine response, and intermittent neutropenia. Immunophenotyping revealed reduced CD16+ NK cells and absent naive T cells, mucosal-associated invariant T cells (MAITs), and invariant natural killer T cells (iNKTs). Lymphocytic defects were characterized by T cell receptor (TCR) oligoclonality, abnormal class switch recombination (CSR), and impaired T cell proliferation. ATRIP deficiency resulted in low-grade ATR activation but impaired CHK1 phosphorylation upon genotoxic stress. Consequently, ATRIP deficient cells inadequately regulated DNA replication, leading to chromosomal instability, compromised cell cycle control, and impaired cell viability. CRISPR-SelectTIME confirmed reduced cell fitness induced by both variants. This study establishes ATRIP deficiency as a monogenic cause of microcephalic primordial dwarfism, highlights ATRIPs critical role in protecting immune cells from replication stress, and brings a renewed perspective to the canonical functions of ATRIP.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Journal of Experimental Medicine
based on 10 papers
Top 0.1%
13.2%
2
Nature Communications
based on 483 papers
Top 12%
6.7%
3
Journal of Clinical Immunology
based on 11 papers
Top 0.1%
4.9%
4
Scientific Reports
based on 701 papers
Top 40%
4.7%
5
Cell
based on 28 papers
Top 0.3%
4.7%
6
Cell Reports Medicine
based on 49 papers
Top 0.9%
3.1%
7
The Journal of Immunology
based on 19 papers
Top 0.4%
3.1%
8
Nature Immunology
based on 14 papers
Top 0.3%
3.1%
9
PLOS ONE
based on 1737 papers
Top 76%
3.1%
10
Allergy
based on 13 papers
Top 0.7%
2.9%
11
eLife
based on 262 papers
Top 8%
2.9%
50% of probability mass above
12
Clinical Immunology
based on 12 papers
Top 0.3%
2.9%
13
The American Journal of Human Genetics
based on 77 papers
Top 4%
2.9%
14
Journal of Clinical Investigation
based on 50 papers
Top 0.9%
2.5%
15
Immunity
based on 11 papers
Top 0.3%
2.4%
16
Science Immunology
based on 15 papers
Top 0.4%
2.4%
17
Communications Biology
based on 36 papers
Top 0.7%
2.4%
18
Cell Reports
based on 25 papers
Top 0.5%
2.4%
19
Brain
based on 69 papers
Top 5%
1.6%
20
JCI Insight
based on 63 papers
Top 4%
1.6%
21
Nature Medicine
based on 88 papers
Top 7%
1.6%
22
Annals of the Rheumatic Diseases
based on 23 papers
Top 0.9%
1.4%
23
Blood
based on 14 papers
Top 0.7%
1.4%
24
Cell Genomics
based on 34 papers
Top 2%
1.4%
25
Frontiers in Immunology
based on 140 papers
Top 6%
1.2%
26
Clinical Epigenetics
based on 21 papers
Top 1%
1.2%
27
Nature Genetics
based on 72 papers
Top 8%
0.8%
28
Journal for ImmunoTherapy of Cancer
based on 14 papers
Top 3%
0.7%
29
Science Translational Medicine
based on 40 papers
Top 5%
0.7%